date,title,source
Oct-25-18,"Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System",GlobeNewswire
Oct-31-18,Laura Clague Named to Fluidigm Board of Directors,GlobeNewswire
Nov-01-18,"Fluidigm (FLDM) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Fluidigm: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Fluidigm Announces Third Quarter 2018 Financial Results,GlobeNewswire
Nov-01-18,Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development,GlobeNewswire
Nov-06-18,"Research Report Identifies Exelon, La Jolla Pharmaceutical, Kennedy-Wilson, Fluidigm, Telefonica SA, and Cognex with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Nov-07-18,Fluidigm Recognized as a Company to Watch in 2019,GlobeNewswire
Nov-08-18,Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018,GlobeNewswire
Nov-09-18,Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),GlobeNewswire
Nov-12-18,Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference,GlobeNewswire
Nov-16-18,Edited Transcript of FLDM earnings conference call or presentation 1-Nov-18 9:00pm GMT,Thomson Reuters StreetEvents
Dec-11-18,Fluidigm Announces Commencement of Public Offering of Common Stock,GlobeNewswire
Dec-12-18,"Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock",GlobeNewswire
Dec-14-18,"Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares",GlobeNewswire
Jan-08-19,Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring,GlobeNewswire
Jan-14-19,Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Jan-24-19,"Consolidated Research: 2019 Summary Expectations for Marriott International, Calavo Growers, Kinsale Capital Group, Fluidigm, Goldman Sachs BDC, and Stemline Therapeutics  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Jan-31-19,Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1,GlobeNewswire
Feb-07-19,Fluidigm Corp (FLDM) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-07-19,"Fluidigm (FLDM) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Feb-07-19,Fluidigm: 4Q Earnings Snapshot,Associated Press
Feb-07-19,Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Feb-07-19,Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations,GlobeNewswire
Feb-08-19,Edited Transcript of FLDM earnings conference call or presentation 7-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Feb-08-19,Here's Why Fluidigm Rose as Much as 14.2% Today,Motley Fool
Feb-11-19,The 1 Stock I'd Buy Right Now,Motley Fool
Feb-12-19,Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),GlobeNewswire
Feb-12-19,Fluidigm Corporation (NASDAQ:FLDM): Is It A Good Long Term Opportunity?,Simply Wall St.
Feb-19-19,3 Top Stocks That Aren't on Wall Street's Radar,Motley Fool
Feb-19-19,"Detailed Research: Economic Perspectives on Exxon Mobil, Loxo Oncology, Fluidigm, LHC Group, Ebix, and Omega Flex  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
